SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-311793
Filing Date
2022-12-23
Accepted
2022-12-23 16:14:41
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d398276ds3.htm S-3 199125
2 EX-5.1 d398276dex51.htm EX-5.1 8877
3 EX-23.1 d398276dex231.htm EX-23.1 2542
4 EX-FILING FEES d398276dexfilingfees.htm EX-FILING FEES 31642
5 GRAPHIC g398276g01a01.jpg GRAPHIC 595224
6 GRAPHIC g398276g1222082611713.jpg GRAPHIC 1649
7 GRAPHIC g398276g1222085000510.jpg GRAPHIC 6662
  Complete submission text file 0001193125-22-311793.txt   1066612
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268991 | Film No.: 221485529
SIC: 2834 Pharmaceutical Preparations